Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Landiolol in out-of-hospital cardiac arrest
2020-003661-19Phase 2Active
- Sponsor
- Medical University of Vienna
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cardiac arrest (SCA) comparing Rapibloc + standard resuscitation with Placebo + standard resuscitation (2 arms). Primary endpoint: Time to sustained return of spontaneous circulation. Started Aug 2020; status: active.
02
Drugs
landiolol
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2020-003661-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003661-19.